Immune Checkpoint Inhibitors: Management of Immune Related Reactions

Here is a Medical Practice Guideline on the MANAGEMENT OF IMMUNE RELATED ADVERSE EVENTS ASSOCIATED WITH USE OF IMMUNE CHECKPOINT INHIBITORS produced by Dr Jack Burke (Immunology Department, FSH), currently pending approval at SCGH.

 

 

Date implemented – 05/2017
Review date – 05/2020
Author – Dr Jack Burke (Immunology, FSH)

Leave a Comment

Your email address will not be published. Required fields are marked *